Safety and efficacy of belimumab in patients with systemic lupus erythematosus treated in clinical practice

Trial Profile

Safety and efficacy of belimumab in patients with systemic lupus erythematosus treated in clinical practice

Completed
Phase of Trial: Phase IV

Latest Information Update: 09 Nov 2015

At a glance

  • Drugs Belimumab (Primary)
  • Indications Systemic lupus erythematosus
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Nov 2015 New trial record
    • 01 Nov 2015 Results published in The Journal of Rheumatology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top